XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Stock Options | 6 Months Ended
--- | ---
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock Options | NOTE 8 - Stock Options The Company follows ASC 718 “Share-Based Payment”, which requires that all share based payments to employees, including stock options, be recognized as compensation expense in the consolidated financial statements based on their fair values and over the requisite service period. The Company recorded non-cash compensation expense relating to stock-based compensation of $147,000 and $103,000 for the three months ended December 31, 2018 and 2017, respectively ($0.00 per basic and diluted share for each period) and $152,000 and $136,000 for the six months ended December 31, 2018 and 2017, respectively ($0.00 per basic and diluted share for each period) 2012 Employee Stock Option Plan In December 2012, the stockholders approved the 2012 Employee Stock Option Plan (the “2012 Employee Plan”). The 2012 Employee Plan authorizes the granting of awards, the exercise of which would allow up to an aggregate of 950,000 shares of the Company's common stock to be acquired by the holders of such awards. Under this plan, the Company may grant stock options, which are intended to qualify as incentive stock options (“ISOs”), to valued employees. Any plan participant who is granted ISOs and possesses more than 10% of the voting rights of the Company's outstanding common stock must be granted an option with a price of at least 110% of the fair market value on the date of grant. Under the 2012 Employee Plan, stock options may be granted to valued employees with a term of up to 10 years at an exercise price equal to or greater than the fair market value on the date of grant and are exercisable, in whole or in part, at 20% per year beginning on the date of grant. An option granted under this plan shall vest in full upon a “change in control” as defined in the plan. At December 31, 2018, 71,700 stock options were granted and outstanding, 36,500 stock options were exercisable and 797,900 stock options were available for grant under this plan. The fair value of each option granted during the six months ended December 31, 2018 was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
|  | 2018 |
Risk-free interest rates |  |  | 3.1 | %
Expected lives |  |  | 10 years |
Expected volatility |  |  | 52 | %
Expected dividend yields |  |  | 0 | %
The following table reflects activity under the 2012 Employee Plan for the six months ended December 31,:
|  | 2018 |  |  | 2017 |
|  | Options |  |  | Weighted average exercise price |  |  | Options |  |  | Weighted average exercise price |
Outstanding, beginning of year |  |  | 57,200 |  |  | $ | 7.09 |  |  |  | 70,600 |  |  | $ | 5.84 |
Granted |  |  | 24,000 |  |  |  | 15.28 |  |  |  | 20,000 |  |  |  | 8.97 |
Terminated/Lapsed |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | (9,500 | ) |  |  | 5.97 |  |  |  | (2,500 | ) |  |  | 6.31 |
Outstanding, end of period |  |  | 71,700 |  |  | $ | 9.98 |  |  |  | 88,100 |  |  | $ | 6.53 |
Exercisable, end of period |  |  | 36,500 |  |  | $ | 7.84 |  |  |  | 60,300 |  |  | $ | 6.03 |
Weighted average fair value at grant date of options granted |  | $ | 8.76 |  |  |  |  |  |  | $ | 5.54 |  |  |  |  |
Total intrinsic value of options exercised |  | $ | 104,000 |  |  |  |  |  |  | $ | 7,000 |  |  |  |  |
Total intrinsic value of options outstanding |  | $ | 417,000 |  |  |  |  |  |  | $ | 279,000 |  |  |  |  |
Total intrinsic value of options exercisable |  | $ | 290,000 |  |  |  |  |  |  | $ | 221,000 |  |  |  |  |
9,500 and 2,500 stock options were exercised during the six months ended December 31, 2018 and 2017, respectively. $24,000 and $16,000 of cash was received from option exercises during the six months ended December 31, 2018 and 2017, respectively, and the actual tax benefit realized for the tax deductions from option exercises was $13,000 and $0, respectively. The following table summarizes information about stock options outstanding under the 2012 Employee Plan at December 31, 2018:
|  | Options outstanding |  |  | Options exercisable |
Range of exercise prices |  | Number outstanding |  |  | Weighted average remaining contractual life |  |  | Weighted average exercise price |  |  | Number exercisable |  |  | Weighted average exercise price |
$4.29-$16.16 |  |  | 71,700 |  |  |  | 7.9 |  |  | $ | 9.98 |  |  |  | 36,500 |  |  | $ | 7.84 |
|  |  | 71,700 |  |  |  | 7.9 |  |  | $ | 9.98 |  |  |  | 36,500 |  |  | $ | 7.84 |
As of December 31, 2018, there was $262,000 of unearned stock-based compensation cost related to share-based compensation arrangements granted under the 2012 Employee Plan. 24,000 and 20,000 options were granted during the six months ended December 31, 2018 and 2017, respectively. The total fair value of the options vesting during the three months ended December 31, 2018 and 2017 under this plan was $26,000 and $80,000, respectively. The total fair value of the options vesting during the six months ended December 31, 2018 and 2017 under this plan was $39,000 and $80,000, respectively. 2012 Non-Employee Stock Option Plan In December 2012, the stockholders approved the 2012 Non-Employee Stock Option Plan (the “2012 Non-Employee Plan”). This plan authorizes the granting of awards, the exercise of which would allow up to an aggregate of 50,000 shares of the Company's common stock to be acquired by the holders of such awards. Under this plan, the Company may grant stock options to non-employee directors and consultants to the Company and its subsidiaries. Under the 2012 Non-Employee Plan, stock options may be granted with a term of up to 10 years at an exercise price equal to or greater than the fair market value on the date of grant and are exercisable in whole or in part at 20% per year beginning on the date of grant. An option granted under this plan shall vest in full upon a “change in control” as defined in the plan. At December 31, 2018, 27,800 stock options were granted, 13,800 stock options were exercisable and no further stock options were available for grant under this plan. The following table reflects activity under the 2012 Non-Employee Plan for the six months ended December 31,:
|  | 2018 |  |  | 2017 |
|  | Options |  |  | Weighted average exercise price |  |  | Options |  |  | Weighted average exercise price |
Outstanding, beginning of year |  |  | 27,800 |  |  | $ | 6.85 |  |  |  | 14,200 |  |  | $ | 4.69 |
Granted |  |  | — |  |  |  | — |  |  |  | 15,000 |  |  |  | 8.70 |
Terminated/Lapsed |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | 11,000 |  |  |  | 5.36 |  |  |  | — |  |  |  | — |
Outstanding, end of period |  |  | 16,800 |  |  | $ | 7.83 |  |  |  | 29,200 |  |  | $ | 6.75 |
Exercisable, end of period |  |  | 7,800 |  |  | $ | 6.83 |  |  |  | 15,200 |  |  | $ | 5.53 |
Weighted average fair value at grant date of options granted |  |  | n/a |  |  |  |  |  |  | $ | 5.55 |  |  |  |  |
Total intrinsic value of options exercised |  | $ | 120,000 |  |  |  |  |  |  |  | n/a |  |  |  |  |
Total intrinsic value of options outstanding |  | $ | 133,000 |  |  |  |  |  |  | $ | 86,000 |  |  |  |  |
Total intrinsic value of options exercisable |  | $ | 70,000 |  |  |  |  |  |  | $ | 63,000 |  |  |  |  |
11,000 and 0 stock options were exercised during the six months ended December 31, 2018 and 2017, respectively. No cash was received from option exercises during either of the six months ended December 31, 2018 or 2017 and the actual tax benefit realized for the tax deductions from option exercises was $28,000 and $0 , respectively. The following table summarizes information about stock options outstanding under the 2012 Non-Employee Plan at December 31, 2018:
|  | Options outstanding |  |  | Options exercisable |
Range of exercise prices |  | Number outstanding |  |  | Weighted average remaining contractual life |  |  | Weighted average exercise price |  |  | Number exercisable |  |  | Weighted average exercise price |
$4.37 - $8.70 |  |  | 16,800 |  |  |  | 8.1 |  |  | $ | 7.83 |  |  |  | 7,800 |  |  | $ | 6.83 |
|  |  | 16,800 |  |  |  | 8.1 |  |  | $ | 7.83 |  |  |  | 7,800 |  |  | $ | 6.83 |
As of December 31, 2018, there was $50,000 of unearned stock-based compensation cost related to share-based compensation arrangements granted under the 2012 Non-Employee Plan. 0 and 15,000 options were granted during the six months ended December 31, 2018 and 2017, respectively. The total fair value of the options vesting during each of the three months ended December 31, 2018 and 2017 under this plan was $22,000. The total fair value of the options vesting during the six months ended December 31, 2018 and 2017 under this plan was $22,000 and $39,000, respectively. 2018 Non-Employee Stock Option Plan In December 2018, the stockholders approved the 2018 Non-Employee Stock Option Plan (the “2018 Non-Employee Plan”). This plan authorizes the granting of awards, the exercise of which would allow up to an aggregate of 50,000 shares of the Company's common stock to be acquired by the holders of such awards. Under this plan, the Company may grant stock options to non-employee directors and consultants to the Company and its subsidiaries. Under the 2018 Non-Employee Plan, stock options may be granted with a term of up to 10 years at an exercise price equal to or greater than the fair market value on the date of grant and are exercisable in whole or in part at 20% per year beginning on the date of grant. An option granted under this plan shall vest in full upon a “change in control” as defined in the plan. At December 31, 2018, 20,000 stock options were granted, 4,000 stock options were exercisable and 30,000 stock options were available for grant under this plan. The fair value of each option granted during the six months ended December 31, 2018 was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
|  | 2018 |
Risk-free interest rates |  |  | 2.9 | %
Expected lives |  |  | 10 years |
Expected volatility |  |  | 50 | %
Expected dividend yields |  |  | 0 | %
The following table reflects activity under the 2018 Non-Employee Plan for the six months ended December 31,:
|  | 2018 |  |  | 2017 |
|  | Options |  |  | Weighted average exercise price |  |  | Options |  |  | Weighted average exercise price |
Outstanding, beginning of year |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Granted |  |  | 20,000 |  |  |  | 16.20 |  |  |  | — |  |  |  | — |
Terminated/Lapsed |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding, end of period |  |  | 20,000 |  |  | $ | 16.20 |  |  |  | — |  |  | $ | — |
Exercisable, end of period |  |  | 4,000 |  |  | $ | 16.20 |  |  |  | — |  |  | $ | — |
Weighted average fair value at grant date of options granted |  | $ | 10.24 |  |  |  |  |  |  |  | n/a |  |  |  |  |
Total intrinsic value of options exercised |  |  | n/a |  |  |  |  |  |  |  | n/a |  |  |  |  |
Total intrinsic value of options outstanding |  | $ | — |  |  |  |  |  |  |  | n/a |  |  |  |  |
Total intrinsic value of options exercisable |  | $ | — |  |  |  |  |  |  |  | n/a |  |  |  |  |
No stock options were exercised during the six months ended December 31, 2018 or 2017. No cash was received from option exercises during either of the six months ended December 31, 2018 or 2017 and the actual tax benefit realized for the tax deductions from option exercises was $0 for each of these periods. The following table summarizes information about stock options outstanding under the 2018 Non-Employee Plan at December 31, 2018:
|  | Options outstanding |  |  | Options exercisable |
Range of exercise prices |  | Number outstanding |  |  | Weighted average remaining contractual life |  |  | Weighted average exercise price |  |  | Number exercisable |  |  | Weighted average exercise price |
$16.20 |  |  | 20,000 |  |  |  | 9.9 |  |  | $ | 16.20 |  |  |  | 4,000 |  |  | $ | 16.20 |
|  |  | 20,000 |  |  |  | 9.9 |  |  | $ | 16.20 |  |  |  | 4,000 |  |  | $ | 16.20 |
As of December 31, 2018, there was $164,000 of unearned stock-based compensation cost related to share-based compensation arrangements granted under the 2018 Non-Employee Plan. 20,000 and 0 options were granted during the six months ended December 31, 2018 and 2017, respectively. The total fair value of the options vesting during the three months ended December 31, 2018 and 2017 under this plan was $41,000 and $0, respectively. The total fair value of the options vesting during the six months ended December 31, 2018 and 2017 under this plan was $41,000 and $0, respectively. 2002 Employee Stock Option Plan In December 2002, the stockholders approved the 2002 Employee Stock Option Plan (the “2002 Employee Plan”). This plan expired in October 2012. This plan authorized the granting of awards, the exercise of which would allow up to an aggregate of 1,836,000 shares of the Company's common stock to be acquired by the holders of such awards. Under this plan, the Company may have granted stock options, which were intended to qualify as incentive stock options (ISOs), to key employees. Any plan participant who was granted ISOs and possessed more than 10% of the voting rights of the Company's outstanding common stock must have been granted an option with a price of at least 110% of the fair market value on the date of grant. Under the 2002 Employee Plan, stock options have been granted to key employees with a term of 10 years at an exercise price equal to the fair market value on the date of grant and are exercisable in whole or in part at 20% per year from the date of grant. At December 31, 2018, no stock options were granted or exercisable and no further stock options were available for grant under this plan after the plans expiration in October 2012. The following table reflects activity under the 2002 Employee plan for the six months ended December 31,:
|  | 2018 |  |  | 2017 |
|  | Options |  |  | Weighted average exercise price |  |  | Options |  |  | Weighted average exercise price |
Outstanding, beginning of year |  |  | — |  |  | $ | — |  |  |  | 5,000 |  |  | $ | 5.35 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Terminated/Lapsed |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | (5,000 | ) |  |  | 5.35 |
Outstanding, end of period |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Exercisable, end of period |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Weighted average fair value at grant date of options granted |  |  | n/a |  |  |  |  |  |  |  | n/a |  |  |  |  |
Total intrinsic value of options exercised |  |  | n/a |  |  |  |  |  |  | $ | 20,000 |  |  |  |  |
Total intrinsic value of options outstanding |  |  | n/a |  |  |  |  |  |  |  | n/a |  |  |  |  |
Total intrinsic value of options exercisable |  |  | n/a |  |  |  |  |  |  |  | n/a |  |  |  |  |
0 and 5,000 stock options were exercised during the six months ended December 31, 2018 and 2017, respectively. The 5,000 exercises were settled in cashless exercises by exchanging 2,815 shares of the Company’s common stock which were retired and returned to unissued status. No cash was received from option exercises during either of the three or six months ended December 31, 2018 and 2017 and the actual tax benefit realized for the tax deductions from option exercises was $0 for each of these periods.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration